Brought to you by:
Powered by wagescape.com
Labor Market Pulse
WI NONMETROPOLITAN AREA Edition
Focus: LIFE SCI
2.7%
Wisconsin unemployment rate
vs 4.1% national rate, Sept 2026
3.7%
Statewide wage growth, 2026 projected
Down from 4.2% growth in 2025
$125,962
Validation Engineer advertised pay, metro
vs $108,377 national median
56 notices / 3,914 workers
Wisconsin WARN notices, 2026 YTD
Down 7% from 2025
This Month's Takeaways
Metro median advertised pay of $125,962 sits well above the $108,377 national figure, pointing to acute local scarcity in manufacturing validation — a specialty already flagged statewide as hard-to-fill. Expect this premium to persist as biologics manufacturing capacity expands.
Metro advertised pay of $108,813 is rising sharply while the national figure holds flat near $104,000, consistent with national reporting that senior regulatory talent is in short global supply. Nonmetro employers competing for this function should expect to pay above the national baseline, not at it.
Wisconsin's deceleration from 4.2% to a projected 3.7% wage growth reduces across-the-board compensation pressure, but it does not solve scarcity in DMPK, CMC development, or QA leadership roles the state has flagged as chronically hard to fill. Treat the slowdown as breathing room for budget planning, not a signal to pull back on specialty premiums.
Metro median pay for this role fell sharply to $115,389, trailing the national figure's more modest decline — worth testing against whether local clinical data work is consolidating toward centralized or outsourced models rather than signaling genuine easing in talent demand.
Local Labor Conditions
Wisconsin's nonmetro counties remain in a low-hire, low-fire pattern consistent with the state's 2.7% unemployment rate and 64.5% labor force participation, both well above national averages, leaving a shallow pool of available specialized scientific talent outside Madison and Milwaukee. Statewide wage growth is decelerating to a projected 3.7% for 2026 from 4.2% in 2025, while inflation erodes real gains — a dynamic that softens outside poaching pressure on rural biotech and manufacturing sites but does nothing to ease the underlying scarcity of credentialed talent.
Leadership & Talent Implications
Thin nonmetro labor supply combined with slowing wage growth creates an unusual window: competitive pressure on pay is easing even as scarcity in regulatory, CMC, and validation roles persists, meaning retention risk is more about role-specific flight to Madison, Chicago, or remote-eligible national employers than local wage competition. Advertised pay for Validation Engineer and Regulatory Affairs Specialist roles in this market is running meaningfully above national medians, suggesting nonmetro employers are already paying a scarcity premium to secure functions that can't be easily outsourced to a CDMO or CRO. Organizations should evaluate whether current validation and regulatory affairs offers reflect this local premium before assuming statewide wage deceleration applies evenly across specialized functions.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | $88,178 | $111,019 | $117,649 | ↑ Significant increase | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $73,263 | $123,249 | $124,696 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $35,108 | $40,560 | $45,760 | ↓ Significant decline | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $89,547 | $108,813 | $108,814 | ↑ Significant increase | $104,000 | → Stable |
| Clinical Data Manager | $93,990 | $115,389 | $122,804 | ↓ Significant decline | $123,031 | ↓ Moderate decline |
| Biostatistician | — | — | — | — No data | $133,322 | ↑ Moderate increase |
| Validation Engineer | $98,839 | $125,962 | $130,000 | ↑ Significant increase | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Early indicator
Watch whether Catalent's Madison facility and similar CDMO capacity expand hiring in coming months — continued outsource-capacity growth could reinforce build-vs-outsource decisions for nonmetro biotechs weighing internal manufacturing headcount.
Emerging pressure point
Wisconsin WARN filings are down 7% year over year, but manufacturing remains the historically dominant layoff category; any uptick in nonmetro manufacturing notices could release validation or QA talent into a market currently starved of it.
Worth watching
Track whether the 64% of biopharma organizations nationally still actively recruiting translates into nonmetro Wisconsin postings — national selective hiring amid layoffs could tighten competition for regulatory and CMC talent even as state wage growth slows.
Potential inflection point
Inflation eroding real wage gains statewide may push nonmetro scientific and technical staff to test the market for the first time in years; monitor attrition signals in quality and manufacturing roles that have been stable through 2026.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.